hydrochlorothiazide has been researched along with Menopause in 5 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In six women with postmenopausal osteoporosis, most of whom responded to 50 micrograms/day 25-hydroxyvitamin D (25-OHD) therapy with a rise in intestinal calcium (Ca) absorption, 50 mg/day hydrochlorothiazide (TZ) were added to determine whether the resulting decline in urinary Ca would cause Ca retention in the skeleton." | 7.67 | Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis. ( Glass, K; Nicar, MJ; Pak, CY; Sakhaee, K; Zerwekh, JE, 1984) |
| "In six women with postmenopausal osteoporosis, most of whom responded to 50 micrograms/day 25-hydroxyvitamin D (25-OHD) therapy with a rise in intestinal calcium (Ca) absorption, 50 mg/day hydrochlorothiazide (TZ) were added to determine whether the resulting decline in urinary Ca would cause Ca retention in the skeleton." | 3.67 | Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis. ( Glass, K; Nicar, MJ; Pak, CY; Sakhaee, K; Zerwekh, JE, 1984) |
| "Treatment with hydrochlorothiazide (50 mg/day) produced a decline in fasting urinary Ca (to 0." | 1.27 | Postmenopausal osteoporosis as a manifestation of renal hypercalciuria with secondary hyperparathyroidism. ( Glass, K; Nicar, MJ; Pak, CY; Sakhaee, K, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alekseeva, NP | 1 |
| Belova, EV | 1 |
| Larin, VG | 1 |
| Akhundov, FIu | 1 |
| Krasina, GF | 1 |
| Kotliarova, LV | 1 |
| Sakhaee, K | 2 |
| Nicar, MJ | 2 |
| Glass, K | 2 |
| Zerwekh, JE | 1 |
| Pak, CY | 2 |
| Reid, IR | 1 |
| Ames, RW | 1 |
| Orr-Walker, BJ | 1 |
| Clearwater, JM | 1 |
| Horne, AM | 1 |
| Evans, MC | 1 |
| Murray, MA | 1 |
| McNeil, AR | 1 |
| Gamble, GD | 1 |
| Kamel, HK | 1 |
1 trial available for hydrochlorothiazide and Menopause
| Article | Year |
|---|---|
Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial.
Topics: Absorptiometry, Photon; Aged; Bone Density; Calcium; Diuretics; Double-Blind Method; Drug Administra | 2000 |
4 other studies available for hydrochlorothiazide and Menopause
| Article | Year |
|---|---|
[The use of nebivolol in menopausal women with hypertension].
Topics: Age Factors; Antihypertensive Agents; Benzopyrans; Diuretics; Drug Therapy, Combination; Ethanolamin | 2003 |
Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis.
Topics: Aged; Bone and Bones; Calcifediol; Calcium; Drug Therapy, Combination; Female; Humans; Hydrochloroth | 1984 |
Low-dose thiazide and bone density.
Topics: Aged; Antihypertensive Agents; Bone Density; Calcium; Female; Humans; Hydrochlorothiazide; Kidney Tu | 2002 |
Postmenopausal osteoporosis as a manifestation of renal hypercalciuria with secondary hyperparathyroidism.
Topics: Aged; Bone and Bones; Calcium; Female; Humans; Hydrochlorothiazide; Hyperparathyroidism, Secondary; | 1985 |